General
Preferred name
SUPLATAST
Synonyms
SUPLATAST TOSYLATE ()
SUPLATAST TOSILATE ()
IPD 1151T ()
IPD-1151T ()
Suplatast (Tosilate) ()
IPD-1151T, Suplatast Tosilate ()
Tosilato de suplatast ()
Tosilate de suplatast ()
Ipd ()
Suplatast ion ()
Suplatast cation ()
Suplatast (tosylate) ()
P&D ID
PD014303
CAS
94055-75-1
94055-76-2
Tags
available
drug
Drug indication
Allergy
Drug Status
approved
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Suplatast Tosilate (IPD 1151T) is an orally active Th2 cytokine inhibitor which can inhibit both IL-4 and IL-5 production from Th2 cells and suppress IgE synthesis. Suplatast Tosilate is an anti-allergic agent. Suplatast Tosilate has antiasthmatic, anti-inflammatory and antifibrotic activity[1][2][3][4].
PRICE
29
DESCRIPTION
Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug with an IC50 above 100 ??M, inhibiting both IgE production and the synthesis of IL-4 and IL-5.
DESCRIPTION
Suplatast Tosilate is a novel capsular anti-asthmatic agent that suppresses both IgE production, IL-4 and IL-5 synthesis with IC50 above 100 μM.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Th2 cytokine synthesis inhibitor; antiasthmatic
(Tocriscreen Total)
DESCRIPTION
Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug with an IC50 above 100 μM, inhibiting both IgE production and the synthesis of IL-4 and IL-5.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
17
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
38
Molecular Weight
328.16
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
10
Ring Count
1
Aromatic Ring Count
1
cLogP
1.67
TPSA
67.79
Fraction CSP3
0.56
Chiral centers
1.0
Largest ring
6.0
QED
0.64
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Interleukin
Th2 cytokine
Interleukin Related
Interleukins
MOA
IL Receptor inhibitor
Pathway
Immunology/Inflammation
Source data

